Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02778282 · ClinicalTrials.gov registry record · NA

MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence

A NA study of Opioid Use Disorder, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
27
Enrollment target
3
Study locations

NCT02778282 is a NA study of Opioid Use Disorder that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 27 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02778282, a NA study of Opioid Use Disorder, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
3
Study locations

Study Summary

The goal of the MySafeRx study is to evaluate the feasibility, acceptability, and usability of a novel platform that integrates text messaging reminders, secure electronic pill organizers, and daily remote brief motivational recovery support visits with a standardized protocol for supervised self- administration of buprenorphine via videoconferencing.

Conditions Studied

Opioid Use Disorder

Interventions

  • OTHER MySafeRx™

Study Locations (3)

Vermont

  • Hawthorn Recovery Center - Bennington
  • Mount Anthony Primary Care - Bennington

Massachusetts

  • Cambridge Health Alliance Outpatient Addiction Services - Somerville

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2017-03-24
Est. Completion 2021-08-31
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02778282

The ClinicalTrials.gov registry entry for NCT02778282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which MySafeRx™ is the first listed.

NCT02778282 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Vermont, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02778282 about?

NCT02778282 is a clinical study titled "MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence". The goal of the MySafeRx study is to evaluate the feasibility, acceptability, and usability of a novel platform that integrates text messaging reminders, secure electronic pill organizers, and daily remote brief motivational recovery support visits with a standardized protocol for supervised self- a...

What is the current status of trial NCT02778282?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2017-03-24. Estimated completion is 2021-08-31.

What conditions does trial NCT02778282 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT02778282?

The interventions under investigation include: MySafeRx™ (OTHER).

Who is sponsoring clinical trial NCT02778282?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02778282 being conducted?

This trial has 3 study locations across Massachusetts, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.